My feeling is that I am unsufficiently informed.
We all know results from testing the HIV vaccine are pending. And how could it be any different when the company actively seeks for a sale of the company that Mr. Kempers knows the results? I think nobody would try that in this situation. Therefore I am pretty sure Mr. Kempers knows either about poor results and they just want to sell the rest of the company (in particular the birch pollen project, probably) or he knows about a good outcome from the HIV tests and they think it's an ideal situation to sell the company instead of financing making the vaccine ready for the market.
In either way I think we should know the results, because potential buyers will surely get them. So, why don't we get them? Are these secret?
In any case this lack of information prevents me from making profound investment decisions.
My impression is that we got contradictory signs. Recently I wrote it: On the one hand Mr. Kempers executes options (I think he paid for the shares. Hope I am right in this) and on the other hand many other options don't get touched. I don't know what will happen to these in the case of a sale of the company. Will they expire or will the owners be compensated? If the latter is true, I wouldn't be concerned and Mr. Kempers exercise may have been a friendly hint to us shareholders.
Everything depends on the HIV vaccine, now. The company has immense debt. If I am right, everything below about 80 million would mean a total loss for us. Probably many shareholders would need at least 100 million to not loose money.
To get to the point: I know nothing and can't make decisions.
I am curious about todays trading as well.
